Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

MLA

Yoshikazu Kinoshita, et al. “Randomised Clinical Trial: A Multicentre, Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of Rabeprazole 5 Mg or 10 Mg Once Daily in Patients with Non-Erosive Reflux Disease.” Alimentary Pharmacology & Therapeutics, vol. 33, Nov. 2010, pp. 213–24. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2010.04508.x.

APA

Yoshikazu Kinoshita, Michio Hongo, & K. Ashida. (2010). Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Alimentary Pharmacology & Therapeutics, 33, 213–224. https://doi.org/10.1111/j.1365-2036.2010.04508.x

Chicago

Yoshikazu Kinoshita, Michio Hongo, and K. Ashida. 2010. “Randomised Clinical Trial: A Multicentre, Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of Rabeprazole 5 Mg or 10 Mg Once Daily in Patients with Non-Erosive Reflux Disease.” Alimentary Pharmacology & Therapeutics 33 (November): 213–24. doi:10.1111/j.1365-2036.2010.04508.x.